Recent data indicate that stromal SRD5A2 promotes prostate growth in Benign Prostatic Hyperplasia (BPH) via a paracrine WNT5A-LEF1-IGF1 signaling axis. Here, LEF1 is linked to benign prostatic hyperplasia.